| Ticker Details |
Retractable Technologies, Inc
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. It offers 1mL tuberculin; allergy antigen VanishPoint syringes.
|
| IPO Date: |
May 4, 2001 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$20.06M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.11 | 3.48%
|
| Avg Daily Range (30 D): |
$0.02 | 2.72%
|
| Avg Daily Range (90 D): |
$0.02 | 2.86%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.1M |
| Avg Daily Volume (30 D): |
.04M |
| Avg Daily Volume (90 D): |
.08M |
| Trade Size |
| Avg Trade Size (Sh.): |
216 |
| Avg Trade Size (Sh.) (30 D): |
233 |
| Avg Trade Size (Sh.) (90 D): |
322 |
| Institutional Trades |
| Total Institutional Trades: |
35 |
| Avg Institutional Trade: |
$1.35M |
| Avg Institutional Trade (30 D): |
$3.19M |
| Avg Institutional Trade (90 D): |
$3.19M |
| Avg Institutional Trade Volume: |
.17M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.14M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
317K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.22
|
$.01
|
$
|
|
Diluted EPS
|
$-.22
|
$.01
|
$
|
|
Revenue
|
$37.9M
|
$10.09M
|
$10.45M
|
|
Gross Profit
|
$-.92M
|
$1.69M
|
$-.11M
|
|
Net Income / Loss
|
$-6.45M
|
$.37M
|
$-.09M
|
|
Operating Income / Loss
|
$-20.68M
|
$-3.65M
|
$-5.13M
|
|
Cost of Revenue
|
$38.82M
|
$8.4M
|
$10.55M
|
|
Net Cash Flow
|
$-.47M
|
$.4M
|
$-.34M
|
|
PE Ratio
|
|
|
|
|
|
|